| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/28/2007 | CN1922187A Multi-nuclear metal complexes partially encapsulated by cucurbit[7-12] urils |
| 02/28/2007 | CN1922185A Pyrazolotriazines as kinase inhibitors |
| 02/28/2007 | CN1922184A 7H-pyrrolopyrimidine derivatives |
| 02/28/2007 | CN1922182A Pyrrolotriazine compounds as kinase inhibitors |
| 02/28/2007 | CN1922178A Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds |
| 02/28/2007 | CN1922171A Pyrimidine derivative |
| 02/28/2007 | CN1922158A Isothiourea derivatives |
| 02/28/2007 | CN1922147A Novel style heterocyclic compound as insulin-like growth factors first type acceptor inhibitor |
| 02/28/2007 | CN1922139A Bicyclic amide derivatives |
| 02/28/2007 | CN1921883A Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its use for the treatment of angiogenic-related disorders |
| 02/28/2007 | CN1921882A Allogeneic tumor therapeutic agent |
| 02/28/2007 | CN1921878A Proteins belonging to the bcl-2 family and fragments thereof, and their use in cancer patients |
| 02/28/2007 | CN1921875A Beverage and medicine having bamboo extractive as main component |
| 02/28/2007 | CN1921871A Physiologically active composition and process for producing the same |
| 02/28/2007 | CN1921864A Treatment of malignant gliomas with TGF-beta inhibitors |
| 02/28/2007 | CN1920045A Co-expression carrier and eukaryon expressing carrier capable of inducing cell immune response |
| 02/28/2007 | CN1919874A Antibody molecule ATF-Fc fusion albumen of antiurokinase type fibrinolysin activator receptor and use thereof |
| 02/28/2007 | CN1919873A Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof |
| 02/28/2007 | CN1919872A Fusion albumen containing HSP70 ATPase structure field and antigen peptide and application thereof |
| 02/28/2007 | CN1919871A B7. 1-CD19scFv fusion gene engineering albumen for treating B lymphocyte leukemia and lymph tumour and use thereof |
| 02/28/2007 | CN1919870A Cat alpha interferon, encode gene and application thereof |
| 02/28/2007 | CN1919861A 20(s)-protopanaxadiol glycosylated derivative and preparation method and application thereof |
| 02/28/2007 | CN1919856A Caulis trachelospermi total lignans extractive, extraction method and medicine use of the extractive and active constituent thereof |
| 02/28/2007 | CN1919853A Phosphor isoquinolinone, derivative, synthesis method and use thereof |
| 02/28/2007 | CN1919342A Canine tumor treatment method, pharmaceutical formulation applied thereto, and method of cryogenically preserving cells used therewith |
| 02/28/2007 | CN1919339A Cucurbitacin nano preparation comprising protein, preparation method and use thereof |
| 02/28/2007 | CN1919328A Chinese medicinal compound formulation of anticancer zanthoxylum and curcuma zedoaria |
| 02/28/2007 | CN1919314A Traditional medicine compositions and its application |
| 02/28/2007 | CN1919258A Application of schisandra chinensis in the preparation of medicine for preventing and reducing toxic and side effect of antitumor agent |
| 02/28/2007 | CN1919214A Monascus soft capsule and its preparation method |
| 02/28/2007 | CN1919213A Monascus pellet and its preparing method |
| 02/28/2007 | CN1919208A Medicine for treating epithelium tumor |
| 02/28/2007 | CN1919207A Gariic and medlar capsule |
| 02/28/2007 | CN1919193A Application of biphenyl cyclo-octadiene lignans for reducing toxic and side effect of antitumor agent |
| 02/28/2007 | CN1919192A Curcumenol self-emulsifying capsule and preparation method thereof |
| 02/28/2007 | CN1919190A Composite intravenous injection emulsion of paclitaxel and traditional medicine volatile oil and its preparation process |
| 02/28/2007 | CN1919181A Amphipathic fluorescence target nano micelle and its preparation method |
| 02/28/2007 | CN1919180A Anticancer slow release agent of nimustine and its progression agent |
| 02/28/2007 | CN1919179A Anticancer slow release preparation of nimustine and its progression agent |
| 02/28/2007 | CN1919178A Nimustine slow release injection for treating noumenal tumour |
| 02/28/2007 | CN1919177A Nimustine slow release agent for treating noumenal tumour |
| 02/28/2007 | CN1919176A Anticancer slow release agent of nimustine and its progression agent |
| 02/28/2007 | CN1919175A Medicinal composition of nimustine and its progression agent |
| 02/28/2007 | CN1919174A Anticancer slow release agent of nimustine and its progression agent |
| 02/28/2007 | CN1919173A Nimustine slow release injection for treating extracranial noumenal tumour |
| 02/28/2007 | CN1919172A Anticancer slow release agent of nimustine and its progression agent |
| 02/28/2007 | CN1919171A Medicinal composition of nimustine and its progression agent |
| 02/28/2007 | CN1302107C Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth |
| 02/28/2007 | CN1302103C CD 19XCD3 specific polypeptides and uses thereof |
| 02/28/2007 | CN1301975C 1,2-diaryl benzimidazole derivative for treating illnesses associated with microglia activation |
| 02/28/2007 | CN1301968C Substituied ureaalkyl urea vitamin A protagonist ii |
| 02/28/2007 | CN1301966C 2-amino-2-alkyl-5-heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 02/28/2007 | CN1301748C Antineoplastic nanometer heat sensitive target medicine carrier used combined with chemical therapy and heat therapy |
| 02/28/2007 | CN1301740C Antitumor medicine and its production process |
| 02/28/2007 | CN1301723C Method for purifying and preparing anti-tumor factor-cathepsin beta inhibiting factor from soybean or bean dregs |
| 02/28/2007 | CN1301713C Stephanine soft capsule, and its preparation method |
| 02/28/2007 | CN1301712C Indolyl-3-glyoxylic acid derivatives comprising therapeutically valuable properties |
| 02/28/2007 | CN1301710C Therapeutic methods and compositions involving isoflavones |
| 02/28/2007 | CA2519535A1 Development of natural killer cells and functional natural killer cell lines |
| 02/27/2007 | US7183440 Pharmaceutically useful compounds |
| 02/27/2007 | US7183400 Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes |
| 02/27/2007 | US7183389 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183320 For therapy of neoplastic diseases |
| 02/27/2007 | US7183319 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 02/27/2007 | US7183318 Substituted cyclic compounds, preparation method and pharmaceutical compositions containing them |
| 02/27/2007 | US7183312 Compounds for use as antigrowth agents or antitumor agents and with solvents |
| 02/27/2007 | US7183311 NF-κB inhibitors |
| 02/27/2007 | US7183307 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/27/2007 | US7183304 Heterocyclic compounds and methods of use |
| 02/27/2007 | US7183298 Carbamic acid compounds comprising a sulfonamide linkage as HDAC inhibitors |
| 02/27/2007 | US7183297 For therapy of rheumatoid arthritis, osteoarthritis, asthma, psoriasis, eczema, allergic rhinitis, allergic conjunctivitis, adult respiratory distress syndrome, chronic pulmonary inflammation, chronic obstructive pulmonary disease, chronic heart failure, silicosis, endotoxemia, toxic shock syndrome |
| 02/27/2007 | US7183296 Anti-HIV pyrazole derivatives |
| 02/27/2007 | US7183293 Enzyme inhibitors for phosphodiesterase isozymes for treatment of asthma, chronic bronchitis and chronic obstructive pulmonary disease |
| 02/27/2007 | US7183290 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 02/27/2007 | US7183288 2-phenylamino-4-pyrimidinecarboxamides; coupling a phenylamine with a halopyrimidine, or coupling a halobenzene with an aminopyrimidine, or amidating the 2-phenylamino-4-pyrimidylacylhalide, or oxidizing the 2-phenylamino-4-cyanopyrimidine |
| 02/27/2007 | US7183277 Alpha-((aryl or heteroaryl)ureido or carbamoyloxy)-N-heteroaryl amides; blood-coagulation factor Xa and VIIa inhibitors; synergistic mixtures with other antitumor agents or anticoagulants |
| 02/27/2007 | US7183274 Piperidine-2,6-diones heterocyclically substituted in the 3-position |
| 02/27/2007 | US7183251 hCG therapy for the treatment of breast cancer |
| 02/27/2007 | US7183101 NCC2705—the genome of a bifidobacterium |
| 02/27/2007 | US7182942 Vaccine immunotherapy for immune suppressed patients |
| 02/22/2007 | WO2007022520A2 Antibody-mediated enhancement of immune response |
| 02/22/2007 | WO2007022511A2 Listeria-induced immunorecruitment and activation, and methods of use thereof |
| 02/22/2007 | WO2007022475A1 Fas binding antibodies |
| 02/22/2007 | WO2007022102A2 Pentacyclic kinase inhibitors |
| 02/22/2007 | WO2007021966A1 Pyrazole compounds that modulate hsp90 activity |
| 02/22/2007 | WO2007021877A1 Imidazole compounds that modulate hsp90 activity |
| 02/22/2007 | WO2007021839A2 Polyamines useful as anti-parasitic and anti-cancer therapeutics and as lysine-specific demethylase inhibitors |
| 02/22/2007 | WO2007021825A2 Treatment of proliferative disorders |
| 02/22/2007 | WO2007021794A1 Substituted imidazole compounds as ksp inhibitors |
| 02/22/2007 | WO2007021234A1 Boron compounds useful in bnct |
| 02/22/2007 | WO2007021034A1 Scavenger of harmful active oxygen and/or free radical in living body |
| 02/22/2007 | WO2007020935A1 Therapeutic agent for pain comprising p2y12 receptor and/or p2y14 receptor blocker |
| 02/22/2007 | WO2007020888A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 02/22/2007 | WO2007020880A1 Method of producing lymphocytes |
| 02/22/2007 | WO2007020645A1 Gene silencing of protease activated receptor 1 (par1) |
| 02/22/2007 | WO2007020509A1 Combination of methylol transfer agents with tumour-inhibiting proteins or peptides and the use thereof for the treatment of cancer or tumor growth |
| 02/22/2007 | WO2007020459A2 Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma |
| 02/22/2007 | WO2007020244A1 The mitochondrial rhomboid protease parl as a target for lymphoma |
| 02/22/2007 | WO2007020222A2 Pharmaceutical composition containing as active substance a protein fraction extracted from oviparous embryos at the cell differentiation stage and preparation process thereof |